JP2018184448A5 - - Google Patents

Download PDF

Info

Publication number
JP2018184448A5
JP2018184448A5 JP2018139536A JP2018139536A JP2018184448A5 JP 2018184448 A5 JP2018184448 A5 JP 2018184448A5 JP 2018139536 A JP2018139536 A JP 2018139536A JP 2018139536 A JP2018139536 A JP 2018139536A JP 2018184448 A5 JP2018184448 A5 JP 2018184448A5
Authority
JP
Japan
Prior art keywords
hematopoietic stem
cells
cell
use according
progenitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2018139536A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018184448A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018184448A publication Critical patent/JP2018184448A/ja
Publication of JP2018184448A5 publication Critical patent/JP2018184448A5/ja
Withdrawn legal-status Critical Current

Links

JP2018139536A 2010-08-12 2018-07-25 改善された造血幹細胞および前駆細胞療法 Withdrawn JP2018184448A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37321210P 2010-08-12 2010-08-12
US61/373,212 2010-08-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018031941A Division JP6574279B2 (ja) 2010-08-12 2018-02-26 改善された造血幹細胞および前駆細胞療法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019197587A Division JP2020029458A (ja) 2010-08-12 2019-10-30 改善された造血幹細胞および前駆細胞療法

Publications (2)

Publication Number Publication Date
JP2018184448A JP2018184448A (ja) 2018-11-22
JP2018184448A5 true JP2018184448A5 (enExample) 2019-01-10

Family

ID=45568224

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2013524254A Expired - Fee Related JP6047489B2 (ja) 2010-08-12 2011-08-12 改善された造血幹細胞および前駆細胞療法
JP2016124416A Expired - Fee Related JP6346917B2 (ja) 2010-08-12 2016-06-23 改善された造血幹細胞および前駆細胞療法
JP2018031941A Expired - Fee Related JP6574279B2 (ja) 2010-08-12 2018-02-26 改善された造血幹細胞および前駆細胞療法
JP2018139536A Withdrawn JP2018184448A (ja) 2010-08-12 2018-07-25 改善された造血幹細胞および前駆細胞療法
JP2019197587A Withdrawn JP2020029458A (ja) 2010-08-12 2019-10-30 改善された造血幹細胞および前駆細胞療法
JP2021172986A Withdrawn JP2022009404A (ja) 2010-08-12 2021-10-22 改善された造血幹細胞および前駆細胞療法
JP2023071598A Pending JP2023109761A (ja) 2010-08-12 2023-04-25 改善された造血幹細胞および前駆細胞療法

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2013524254A Expired - Fee Related JP6047489B2 (ja) 2010-08-12 2011-08-12 改善された造血幹細胞および前駆細胞療法
JP2016124416A Expired - Fee Related JP6346917B2 (ja) 2010-08-12 2016-06-23 改善された造血幹細胞および前駆細胞療法
JP2018031941A Expired - Fee Related JP6574279B2 (ja) 2010-08-12 2018-02-26 改善された造血幹細胞および前駆細胞療法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2019197587A Withdrawn JP2020029458A (ja) 2010-08-12 2019-10-30 改善された造血幹細胞および前駆細胞療法
JP2021172986A Withdrawn JP2022009404A (ja) 2010-08-12 2021-10-22 改善された造血幹細胞および前駆細胞療法
JP2023071598A Pending JP2023109761A (ja) 2010-08-12 2023-04-25 改善された造血幹細胞および前駆細胞療法

Country Status (9)

Country Link
US (2) US20140030232A1 (enExample)
EP (2) EP2603227B1 (enExample)
JP (7) JP6047489B2 (enExample)
CN (5) CN103167876B (enExample)
AU (1) AU2011289245B2 (enExample)
BR (1) BR112013003366A2 (enExample)
CA (1) CA2807944C (enExample)
ES (1) ES2654994T3 (enExample)
WO (1) WO2012021845A2 (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2603227B1 (en) * 2010-08-12 2017-10-04 Fate Therapeutics, Inc. Improved hematopoietic stem and progenitor cell therapy
US10111907B2 (en) 2011-12-02 2018-10-30 Fate Therapeutics, Inc. Methods of treating ischemia
PT2785834T (pt) 2011-12-02 2020-11-13 Fate Therapeutics Inc Composição de células estaminais melhorada
WO2014078617A1 (en) * 2012-11-16 2014-05-22 Albert Einstein College Of Medicine Of Yeshiva University Identification and use of new tumor-promoting gene in hematological malignancies
SG10201803131TA (en) * 2013-02-18 2018-06-28 Univ Health Network Methods for generating hepatocytes and cholangiocytes from pluripotent stem cells
AU2014236285A1 (en) * 2013-03-14 2015-11-05 Children's Medical Center Corporation Compositions and methods for reprogramming hematopoietic stem cell lineages
US9943545B2 (en) 2013-03-15 2018-04-17 Fate Therapeutics, Inc. Stem cell culture media and methods of enhancing cell survival
WO2014150602A1 (en) * 2013-03-15 2014-09-25 Fate Therapeutics, Inc. Cell potency assay for therapeutic potential
JP2016509863A (ja) 2013-03-15 2016-04-04 ラーソン、マルクス カーレ、トールレイフＬＡＲＳＳＯＮ， Ｍａｒｃｕｓ Ｋａｒｅ， Ｔｏｒｌｅｉｆ 細胞、臍帯血収集のための方法及び装置、並びに細胞の単離のための方法及び装置
RU2525143C1 (ru) * 2013-03-22 2014-08-10 Федеральное государственное бюджетное учреждение науки Государственный научный центр Российской Федерации-Институт медико-биологических проблем Российской академии наук СПОСОБ ЭКСПАНСИИ МОНОНУКЛЕАРНЫХ КЛЕТОК ПУПОВИННОЙ КРОВИ (пкМНК) ex vivo В ПРИСУТСТВИИ МУЛЬТИПОТЕНТНЫХ СТРОМАЛЬНЫХ МЕЗЕНХИМАЛЬНЫХ КЛЕТОК (ММСК)
WO2015077691A2 (en) * 2013-11-22 2015-05-28 Washington University Biomarkers for multiple myeloma
US11278572B2 (en) 2014-07-18 2022-03-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Reducing CXCR4 expression and/or function to enhance engraftment of hematopoietic stem cells
EP3250682A4 (en) * 2015-01-26 2018-08-01 Fate Therapeutics, Inc. Cells with increased immuno-regulatory properties and methods for their use and manufacture
WO2016123100A1 (en) 2015-01-26 2016-08-04 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
WO2016164502A1 (en) * 2015-04-06 2016-10-13 President And Fellows Of Harvard College Compositions and methods for non-myeloablative conditioning
SG10201913752PA (en) * 2015-07-20 2020-03-30 Angiocrine Bioscience Inc Methods and compositions for stem cell transplantation
KR20180033537A (ko) 2015-07-21 2018-04-03 더 칠드런스 메디칼 센터 코포레이션 Pd-l1 발현 조혈 줄기 세포 및 용도
CN108368520B (zh) 2015-11-04 2023-01-17 菲特治疗公司 多能细胞的基因组工程改造
WO2017078807A1 (en) 2015-11-04 2017-05-11 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
RU2628092C1 (ru) * 2016-02-10 2017-08-14 Федеральное государственное бюджетное учреждение науки Государственный научный центр Российской Федерации - Институт медико-биологических проблем Российской академии наук (ГНЦ РФ - ИМБП РАН) Способ получения МСК-ассоциированных недифференцированных гемопоэтических клеток-предшественников с фенотипов CD34+/CD133+
CN105779386B (zh) * 2016-04-06 2019-09-20 南京大学 一种间充质干细胞在制备治疗m5型白血病药物中的应用
CN105886457A (zh) * 2016-05-16 2016-08-24 中国人民解放军军事医学科学院野战输血研究所 诱导干细胞分化成外胚层祖细胞的方法
WO2018073615A1 (en) * 2016-10-21 2018-04-26 Longboat Explorers Ab Methods and compositions for generating hematopoietic cells
CN106754726A (zh) * 2016-12-28 2017-05-31 溯源生命科技股份有限公司 一种提高人间充质干细胞移植和归巢效率的基因治疗方法
JP2020515246A (ja) * 2017-03-14 2020-05-28 オリジェン， インコーポレイテッド ｉＰＳＣのＨＬＡによってインデックスされたリポジトリおよびｉＰＳＣ由来の幹細胞、ならびに関連するシステムおよび方法
US11879137B2 (en) 2017-09-22 2024-01-23 The Children's Medical Center Corporation Treatment of type 1 diabetes and autoimmune diseases or disorders
EP3647413A1 (en) * 2018-10-31 2020-05-06 Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas O.A., M.P. (CIEMAT) Improvements for performing and facilitating the recovery after hematopoietic stem cell transplantation
US20220218759A1 (en) * 2019-05-17 2022-07-14 Deverra Therapeutics Inc. Compositions and methods for improving treatment outcomes for patients having hematological malignancies using an expanded stem cell product
US20220305057A1 (en) * 2019-06-06 2022-09-29 Medeor Therapeutics, Inc. Methods of making cellular products by post- mortem mobilization and harvesting of hematopoietic cells
WO2020256628A1 (en) 2019-06-20 2020-12-24 Amniotics Ab An apparatus for filtering amniotic fluid
CN110585432B (zh) * 2019-08-27 2021-10-15 中国人民解放军第二军医大学 成纤维细胞生长因子受体1在制备防治肠道病毒71型感染药物中的应用
JP7714535B2 (ja) 2019-10-18 2025-07-29 アムニオティクス・アーベー 羊水およびそれに由来する細胞から羊水間葉系幹細胞を得るためのプロセスならびに装置
EP4058564A1 (en) * 2019-11-14 2022-09-21 Amgen Inc. Hematopoietic precursor cell production
CN116507346A (zh) * 2020-09-24 2023-07-28 广州辑因医疗科技有限公司 化合物用于提高人造血干细胞移植效率的用途
CN116568802A (zh) * 2020-10-30 2023-08-08 西湖生物医药科技(上海)有限公司 制备成熟红细胞的体外方法
US12435308B2 (en) 2020-11-06 2025-10-07 Amniotics Ab Immunomodulation by amniotic fluid mesenchymal stem cells
WO2024040061A2 (en) * 2022-08-16 2024-02-22 The Regents Of The University Of California Alleviating graft versus host disease using engineered inkt cells
WO2024186146A1 (ko) * 2023-03-07 2024-09-12 인제대학교 산학협력단 조혈 줄기세포 증식 또는 가동화 촉진용 조성물 및 가동화 조혈 줄기세포 수집방법
WO2026079443A1 (ja) * 2024-10-09 2026-04-16 国立大学法人 東京大学 Ｃｘｃｒ４陽性造血幹細胞の誘導または製造方法および前記ｃｘｃｒ４陽性造血幹細胞を含む細胞集団

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4843155A (en) 1987-11-19 1989-06-27 Piotr Chomczynski Product and process for isolating RNA
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5635387A (en) 1990-04-23 1997-06-03 Cellpro, Inc. Methods and device for culturing human hematopoietic cells and their precursors
US5460964A (en) 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
US5409813A (en) 1993-09-30 1995-04-25 Systemix, Inc. Method for mammalian cell separation from a mixture of cell populations
US5677136A (en) 1994-11-14 1997-10-14 Systemix, Inc. Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
US5709472A (en) * 1995-10-23 1998-01-20 Lifelines Technology, Inc. Time-temperature indicator device and method of manufacture
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
EP0880598A4 (en) 1996-01-23 2005-02-23 Affymetrix Inc RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
US5945337A (en) 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
AU1287799A (en) 1997-10-31 1999-05-24 Affymetrix, Inc. Expression profiles in adult and fetal organs
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
AU2183900A (en) 1998-12-24 2000-07-31 Alcon Laboratories, Inc. Ep4 receptor agonists for treatment of dry eye
EP1219600A4 (en) 1999-08-13 2004-11-03 Taisho Pharmaceutical Co Ltd PROSTAGLANDIN DERIVATIVES
PT1132086E (pt) 2000-01-31 2006-09-29 Pfizer Prod Inc Utilizacao de agonistas selectivos para o receptor da prostaglandina (pge2) 4 (ep4) para o tratamento de falha renal aguda e cronica
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
FR2825261B1 (fr) 2001-06-01 2003-09-12 Maco Pharma Sa Ligne de prelevement du sang placentaire comprenant une poche de rincage
JP4224624B2 (ja) * 2002-04-26 2009-02-18 協和発酵キリン株式会社 造血幹細胞または造血前駆細胞の増殖または生存を支持し得るポリペプチドおよびそれをコードするｄｎａ
US6747037B1 (en) 2003-06-06 2004-06-08 Allergan, Inc. Piperidinyl prostaglandin E analogs
US20050176140A1 (en) * 2004-02-10 2005-08-11 Benedict Daniel J. Method and apparatus for cell culture using a two liquid phase bioreactor
US7147626B2 (en) 2004-09-23 2006-12-12 Celgene Corporation Cord blood and placenta collection kit
JP2008518013A (ja) 2004-10-26 2008-05-29 アラーガン、インコーポレイテッド プロスタグランジンｅｐ４アゴニストによる処置方法およびデリバリー方法
DE102005062741A1 (de) 2005-12-22 2007-06-28 Bayer Schering Pharma Ag Fluorene und Carbazole als Liganden des EP2 Rezeptors
MX373998B (es) * 2006-03-24 2020-07-22 Childrens Medical Center Uso de un modulador de células madre hematopoyeticas (hsc) para promover el crecimiento de hsc.
CN101517070A (zh) * 2006-05-31 2009-08-26 Styx有限责任公司 选择干细胞的方法及其用途
CN101506353A (zh) * 2006-06-15 2009-08-12 尼奥斯泰姆公司 外周造血干细胞的处理方法
WO2009134532A2 (en) * 2008-03-07 2009-11-05 The Trustees Of Columbia University In The City Of New York Homing in mesenchymal stem cells
EP3031907B1 (en) * 2008-11-06 2021-01-06 Indiana University Research and Technology Corporation Materials and methods to enhance hematopoietic stem cells engraftment procedures
EP2367432B1 (en) * 2008-12-03 2017-08-30 Amorcyte, Inc. Infarct area perfusion-improving composition
JP2010193879A (ja) * 2009-01-27 2010-09-09 Jms Co Ltd 臍帯血造血幹細胞の増殖制御方法およびその用途
EP2603227B1 (en) * 2010-08-12 2017-10-04 Fate Therapeutics, Inc. Improved hematopoietic stem and progenitor cell therapy

Similar Documents

Publication Publication Date Title
Keighron et al. Recent advances in endothelial progenitor cells toward their use in clinical translation
Kelly et al. Ex vivo expansion of cord blood
ES2627043T3 (es) Aumento de la eficacia de la terapia celular incluyendo tratamiento con alfa 1-3 fucoslitransferasa
Haider et al. Bone marrow stem cell transplantation for cardiac repair
Aggarwal et al. Hematopoietic stem cells: transcriptional regulation, ex vivo expansion and clinical application
Zhong et al. Feasibility investigation of allogeneic endometrial regenerative cells
Tung et al. Ex vivo expansion of umbilical cord blood for transplantation
ES2638435T3 (es) Métodos y medios para proliferación de células madre y posterior generación y expansión de células progenitoras, así como también producción de células efectoras como terapéuticos clínicos
US20240294873A1 (en) Methods for the long-term expansion of granulocyte-macrophage progenitors and applications thereof
JP2013540105A5 (enExample)
RU2015134394A (ru) Перепрограммирование эндотелия человека в гемопоэтических предшественников множественных линий дифференцировки с использованием определенных факторов
JP2021512903A5 (enExample)
Oh et al. Stem cell and exosome therapy in pulmonary hypertension
JP2024016037A5 (enExample)
Wang et al. Allogeneic stem cell transplantation combined with transfusion of mesenchymal stem cells in primary myelofibrosis: a multicenter retrospective study
US20190201444A1 (en) Glycoengineering of e-selectin ligands
US20110206644A1 (en) Methods for trans-differentiating cells
Kim et al. Cell therapy with bone marrow cells for myocardial regeneration
Metheny et al. Posttransplant intramuscular injection of PLX-R18 mesenchymal-like adherent stromal cells improves human hematopoietic engraftment in a murine transplant model
Quesenberry et al. The new stem cell biology
Turksen Stem cells: Current challenges and new directions
Aanei et al. Evaluation of bone marrow microenvironment could change how myelodysplastic syndromes are diagnosed and treated
Ren et al. Umbilical cord blood hematopoietic stem cell expansion ex vivo
Zhao et al. Research progress on how mesenchymal stem cells regulate hematopoietic stem cell behavior
Suresh et al. Exploring MSC and HSPC interactions: new frontiers in hematopoiesis and transplant medicine